JCRB1941 TU-KatoIII
Cell information
Cell type：general cells (View Pricing Information)
| JCRB No. | JCRB1941 | Cell Name | TU-KatoIII |
|---|---|---|---|
| Profile | Cell line isolated as 100% tumor-forming cells after tumor formation in immunodeficient mice (NOD Scid→Scid→nu/nu). | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | M | Age | 57-year-old |
| Identity | available | Tissue for Primary Cancer | stomach |
| Case history | Signet ring cell gastric adenocarcinoma. Derived from metastatic site: Pleural effusion. | Metastasis | Y |
| Tissue Metastasized | Genetics | ||
| Life Span | infinite | Crisis PDL | |
| Morphology | round shape | Character | floating |
| Classify | tumor | Established by | Yanagihara Kazuyoshi |
| Registered by | Yuki Iino | Regulation for Distribution | |
| Comment | Year | ||
| Medium | RPMI1640 medium + 10% FBS | Methods for Passages | dilution |
| Cell Number on Passage | Race | ||
| CO2 Conc. | 5% | Tissue Sampling | Pleural effusion |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:17505008 | AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor. Takeda M,Arao T,Yokote H,Komatsu T,Yanagihara K,Sasaki H,Yamada Y,Tamura T,Fukuoka K,Kimura H,Saijo N,Nishio K Clin Cancer Res. 2007 May 15;13(10):3051-7 |
| Images |
|---|
      |
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB1941 | Cell Name | TU-KatoIII |
|---|---|---|---|
| LOT No. | 04072023 | Lot Specification | distribution |
| Medium | RPMI1640(GIBCO Cat#11875-093) with 10% heat inactivated fetal bovine serum (SIGMA, Cat#172012, Lot#12J396). | Temperature | 37 C |
| Cell Density at Seeding | 0.6-5.7x10^5 cells/ml | Methods for Passages | Dilution (split ratio=1/2-1/3) |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 4.6x10^6 |
| Viability at cell freezing (%) | 88.90 | Antibiotics Used | free |
| Passage Number | p6* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:10,11 D13S317:8,12 D7S820:8,12 D16S539:12 VWA:14,16 TH01:7 AM:X TPOX:11 CSF1PO:7,11 |
| Adhesion | No | Exoteric Gene | NT |
| Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 80.1 | Additional information | Most cells grow in suspension. |
| Images |
|---|
|
|